## **Core Concept**
Forbe's disease, also known as Forbe's glycogen storage disease, is a genetic disorder caused by the deficiency of a specific enzyme involved in glycogen metabolism. This condition leads to the accumulation of glycogen in various tissues, resulting in cellular dysfunction. The enzyme deficiency associated with Forbe's disease is **acid alpha-glucosidase** (also known as acid maltase), but more accurately, Forbe's disease is related to the deficiency of **glucosylceramidase** or specifically **alpha-glucosidase** for Pompe disease. However, Forbe's disease is another name for **Glycogen Storage Disease Type III**, which is caused by a deficiency in the **debranching enzyme** (alpha-1,6-glucosidase).

## **Why the Correct Answer is Right**
The correct answer, **debranching enzyme (alpha-1,6-glucosidase)**, is implicated in Forbe's disease or Glycogen Storage Disease Type III. This enzyme plays a crucial role in the breakdown of glycogen. It specifically cleaves the alpha-1,6-glycosidic bonds at branch points in glycogen, which is necessary for the complete degradation of glycogen to glucose for energy use. A deficiency in this enzyme leads to the accumulation of abnormal glycogen (limit dextrin) in the liver, muscles, and other tissues, causing the clinical manifestations of the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **alpha-glucosidase** deficiency is related to Pompe disease (Glycogen Storage Disease Type II), it is not the cause of Forbe's disease.
- **Option B:** **Acid alpha-glucosidase** is another term for the enzyme deficient in Pompe disease, not Forbe's disease.
- **Option D:** **Phosphorylase** deficiency is associated with McArdle's disease (Glycogen Storage Disease Type V), which presents differently and is not Forbe's disease.

## **Clinical Pearl / High-Yield Fact**
A key clinical feature of Forbe's disease (Glycogen Storage Disease Type III) is the **progressive liver disease** and **hypoglycemia** due to the inability to properly break down glycogen. Patients may also exhibit **muscle weakness** and **developmental delays**. This condition highlights the importance of debranching enzyme in glycogen metabolism.

## **Correct Answer:** . **debranching enzyme**